Categories AlphaGraphs, Earnings, Health Care

BIIB Earnings: A snapshot of Biogen’s Q2 2023 financial results

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower earnings, on an adjusted basis, and revenues for the second quarter of 2023.

Biogen Q2 2023 earnings infographic

Total revenue declined 5% year-over-year to $2.46 billion. For the full year of 2023, the company expects revenues to decline in the mid-single digit percentage and projects adjusted earnings per share in the range of $15.00 to 16.00.

Net income attributable to Biogen Inc. was $591.6 million or $4.07 per share in Q2, compared to $1.06 billion or $7.24 per share last year. Adjusted earnings declined 23% to $4.02 per share.

Prior Performance

  • Biogen-Q4-2022-Earnings-Infographic
  • Biogen Q3 2022 earnings infographic
  • Biogen Q2 2022 Earnings Infographic

Most Popular

Micron Earnings Preview: Recovery likely to continue as demand bounces back

Micron Technology Inc. (NASDAQ: MU), a market leader in memory and flash storage chips, emerged from a losing streak in the most recent quarter and reported a profit. The recovery

After mixed Q4, Darden Restaurants stays focused on profitable sales growth

Darden Restaurants, Inc. (NYSE: DRI), which owns popular restaurant brands Olive Garden and LongHorn Steakhouse, has reported stronger-than-expected fourth-quarter results, sending the stock higher soon after the announcement. Contributions from

What to expect when McCormick & Company (MKC) reports Q2 2024 earnings results

Shares of McCormick & Company, Incorporated (NYSE: MKC) stayed green on Friday. The stock has dropped 4% over the past one month. The spices and condiments maker is scheduled to report

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top